Jazz Pharmaceuticals plcJAZZ
Close of Friday, October 23, 2026 · Jazz Pharmaceuticals plc is trading below its Pivot, OnlyAlpha's long-term trend line.
Price
$214.01
vs its Pivot
-0.7%
OnlyAlpha Score
27
Trend
Below its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| -9.4% | +25.9% | +54.5% | — | — |
No dividend in the last 12 months.
Who runs and owns it
In these funds
IHE · 3.43%IYH · 0.22%IYY · 0.02%IJH · 0.00%
Big investors that own it (latest 13F)
| Perceptive Advisors | 0.6% of holdings |
Suppliers, customers and partners
Sells to JAZZ
| Cigna Group (Express Scripts/Evernorth) | ESSDS exclusive central pharmacy (Xywav/Xyrem) |
| Zymeworks | Ziihera exclusive license |
From the companies' own annual reports filed with the SEC.
Healthcare · Biotech
Get JAZZ in your free daily emailAfter every close: whether JAZZ is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track JAZZ free → Full Stock check
Track JAZZ free → Full Stock check